Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-04-20
2008-08-19
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C546S268400, C546S268700, C546S286000, C546S275400, C544S124000, C514S340000, C514S341000, C514S342000, C514S343000, C514S344000
Reexamination Certificate
active
07414055
ABSTRACT:
The present invention is directed to compounds which contain a substituted pyridine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
REFERENCES:
patent: 5506219 (1996-04-01), Robl
patent: 5585388 (1996-12-01), Cosford et al.
patent: 5594011 (1997-01-01), McDonald et al.
patent: 5686470 (1997-11-01), Weier et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 6960584 (2005-11-01), Carling et al.
patent: 2002/0127214 (2002-09-01), Hemmings
patent: 2003/0073687 (2003-04-01), Bebbington et al.
patent: 2004/0102360 (2004-05-01), Barnett et al.
patent: 2004/0106540 (2004-06-01), Barnett et al.
patent: 2004/0116433 (2004-06-01), Owens et al.
patent: 2004/0122012 (2004-06-01), Owens et al.
patent: 2005/0130977 (2005-06-01), Lindsley et al.
patent: 2005/0159422 (2005-07-01), Lindsley et al.
patent: 2005/0182256 (2005-08-01), Duggan et al.
patent: 2005/0222155 (2005-10-01), Bilodeau et al.
patent: 2005/0288294 (2005-12-01), Duggan et al.
patent: 356788 (1990-03-01), None
patent: WO 96/15123 (1996-05-01), None
patent: WO 96/23769 (1996-08-01), None
patent: WO 96/24584 (1996-08-01), None
patent: WO 97/22360 (1997-06-01), None
patent: WO 01/91754 (2001-12-01), None
patent: WO 02/083064 (2002-10-01), None
patent: WO 02/083138 (2002-10-01), None
patent: WO 03/011854 (2003-02-01), None
patent: WO 03/075836 (2003-09-01), None
patent: WO 03/084473 (2003-10-01), None
Toker et. al., “Akt Signaling and Cancer: Surviving but not Moving On”, Cancer Res 2006:66(8). Apr. 15, 2006.
Duggan Mark E.
Hartnett John C.
Lindsley Craig W.
Wu Zhicai
Zhao Zhijian
Davis Zinna N
Leff Matthew A.
Merck & Co. , Inc.
Muthard David A.
LandOfFree
Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4018769